Skip to main content

Table 2 Comparison of risk detection rate between JAMRISC and FINDRISC questionnaires

From: Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan

Pathologies

FINDRISC

JAMRISC

Sensitivity

Specificity

Sensitivity

Specificity

MetS (18/83)

44.4 % (8/18)

100.0 % (65/65)

100.0 % (18/18)

72.3 % (47/65)

Pre-MetS (10/83)

0.0 % (0/10)

89.0 % (65/73)

90.0 % (9/10)

63.0 % (46/73)

Type2 diabetes (6/83)

66.7 % (4/6)

94.8 % (73/77)

83.3 % (5/6)

59.7 % (46/77)

Pre-diabetes (13/83)

23.1 % (3/13)

92.8 % (65/70)

92.3 % (12/13)

65.7 % (46/64)

Overall risk for above four pathologiesa (29/83)

27.6 % (8/29)

100.0 % (54/54)

93.1 % (27/29)

83.3 % (45/54)

  1. A sample of 83 subjects (aged 40–60 years) definitively diagnosed as healthy or with MetS, pre-MetS, type 2 diabetes, or pre-diabetes according to the results of regular health checkups completed both JAMRISC and FINDRISC questionnaires simultaneously
  2. aJAMRISC could detect individuals with any risks related to type 2 diabetes and MetS with a sensitivity of 93.1 % and a specificity of 83.3 %, whereas FINDRISC offered high specificity (100.0 %), but markedly low sensitivity (27.6 %)
Back to article page

Environmental Health and Preventive Medicine

ISSN: 1347-4715

Contact us